News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

January 2015

Top

Janssen and Pharmacyclics receive FDA approval for Imbruvica to treat WM
30 January 2015 Janssen Biotech and Pharmacyclics have received approval from the US Food and Drug Administration (FDA) for Imbruvica (ibrutinib) capsules as the first therapy indicated specifically for...

Valeant to acquire US-based Dendreon for $296m
30 January 2015 Canada-based Valeant Pharmaceuticals International has signed a stalking horse agreement to acquire certain assets of US-based Dendreon for $296m in cash. ...

GSK and Novartis three-part transaction receives European approval
29 January 2015 GlaxoSmithKline (GSK) has obtained approval from the European Commission (EC) for its three-part transaction with Novartis....

AstraZeneca enters four research collaborations for genome editing technology
29 January 2015 British-Swedish drugmaker AstraZeneca has entered four research collaborations to use clustered regularly interspaced short palindromic repeats (CRISPR) technology for genome editing across...

Anticholinergic medications increase dementia risk, say scientists
28 January 2015 Taking commonly used medications with anticholinergic effects at higher doses or for prolonged periods has been found to increase the risk of dementia, including Alzheimer’s, according to a...

Pfizer agrees to pay $400m to avoid investor class action lawsuit
28 January 2015 Pfizer has agreed to pay around $400m charge for an agreement in principle to resolve a securities class action pending against the company over off-label promotion actions....

BioCryst’s BCX4161 receives FDA fast-track designation to treat HAE
27 January 2015 BioCryst Pharmaceuticals has received fast-track designation from the US Food and Drug Administration (FDA) for its BCX4161, an orally administered and selective inhibitor of plasma kallikrein...

Actavis to buy UK’s Auden Mckenzie for £306m
27 January 2015 Ireland-based pharmaceutical firm Actavis has signed an agreement to acquire Auden Mckenzie for approximately £306m in cash....

NICE recommends Bayer’s Xarelto to reduce ACS secondary events risk
26 January 2015 The National Institute for Health and Care Excellence (NICE) has recommended Bayer Healthcare's Xarelto (rivaroxaban) as an effective treatment to reduce the risk of secondary events in...

Genzyme’s Cerdelga receives European approval to treat Gaucher disease type 1
23 January 2015 Sanofi subsidiary Genzyme has received marketing approval from European Commission (EC) for its Cerdelga (eliglustat) capsules to treat adult patients with Gaucher disease type...

EMA approves AstraZeneca’s lesinurad to treat gout patients
23 January 2015 British-Swedish drugmaker AstraZeneca has received approval from European Medicines Agency (EMA) for its lesinurad 200mg tablets to treat gout...

Curis and Aurigene to develop small molecule antagonists for oncology targets
22 January 2015 US-based Curis has signed a collaboration agreement with Indian drug-maker Dr. Reddy's Laboratories subsidiary Aurigene Discovery Technologies to discover, develop and commercialise small...

Novartis’ Cosentyx receives FDA approval to treat plaque psoriasis
22 January 2015 Swiss drug-maker Novartis has obtained approval from US Food and Drug Administration for its Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in adult patients who are...

Boehringer Ingelheim’s nintedanib receives European approval to treat IPF
21 January 2015 Germany-based Boehringer Ingelheim has received approval from European Commission (EC) for its nintedanib to treat patients with idiopathic pulmonary fibrosis...

Baxter’s Phoxillum Renal Replacement Solutions obtains FDA approval
21 January 2015 Baxter International has received approval from US Food and Drug Administration (FDA) for its Phoxillum Renal Replacement Solutions (BK4/2.5 and B22K4/0) to use as replacement solutions...

MSG urges GSK and Pfizer to reduce pneumococcal vaccine price
20 January 2015 Médecins Sans Frontières (MSF) has urged GlaxoSmithKline (GSK) and Pfizer to reduce the price of the pneumococcal vaccine to $5 per child in developing countries....

Novartis obtains European approval for Cosentyx to treat psoriasis
20 January 2015 Swiss drug-maker Novartis has received approval from the European Commission (EC) for its Cosentyx (secukinumab, formerly known as AIN457) to treat moderate-to-severe plaque psoriasis in adults...

Neuropore and UCB to develop new therapeutic products for Parkinson’s disease
19 January 2015 US-based Neuropore Therapies has signed an agreement with Belgian biopharmaceutical firm UCB to develop and commercialise therapeutic products to slow progression of Parkinson's disease (PD)...

AbbVie’s Viekirax and Exviera receives European approval for chronic hepatitis C virus
19 January 2015 US-based AbbVie has received marketing authorisation from European Commission (EC) for its all-oral, short-course, interferon-free treatment of Viekirax (ombitasvir / paritaprevir /...

Depomed to acquire Janssen’s Nucynta US franchise rights for $1.5bn
16 January 2015 Pharmaceutical firm Depomed has signed an agreement with Janssen Pharmaceuticals to acquire its US rights to the Nucynta franchise for...

Roche to acquire French biotechnology firm Trophos
16 January 2015 Switzerland-based Roche has agreed to acquire French biotechnology firm Trophos, in a bid to expand its neuromuscular disease...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511